![]() | ![]() |
Formats:
|
||||||||||||||||||||||
Copyright This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. Multiple Reassortment Events in the Evolutionary History of H1N1 Influenza A Virus Since 1918 1Department of Biology, Center for Infectious Disease Dynamics, The Pennsylvania State University, University Park, Pennsylvania, United States of America 2Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America 3Department of Global Health, School of Public Health and Health Services, The George Washington University, Washington, D.C., United States of America 4Wadsworth Center, New York State Department of Health, Albany, New York, United States of America 5The J. Craig Venter Institute, Rockville, Maryland, United States of America 6Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States of America 7Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America 8Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America Yoshihiro Kawaoka, Editor University of Wisconsin-Madison, United States of America * E-mail: ech15/at/psu.edu Conceived and designed the experiments: MN EH. Performed the experiments: RB SG KS JT DS NS EG. Analyzed the data: MN. Wrote the paper: MN CV LS RB SG KS JT DS NS EG JKT EH. Performed the sequence analysis: MN. Advised on epidemiological aspects of the study: CV LS. Collected a subset of the viral samples: RB SG KS JT. Undertook the viral genome sequencing: DS NS EG. Advised on virological aspects of the study: JKT. Received September 20, 2007; Accepted January 17, 2008. This article has been cited by other articles in PMC.Abstract The H1N1 subtype of influenza A virus has caused substantial morbidity and mortality in humans, first documented in the global pandemic of 1918 and continuing to the present day. Despite this disease burden, the evolutionary history of the A/H1N1 virus is not well understood, particularly whether there is a virological basis for several notable epidemics of unusual severity in the 1940s and 1950s. Using a data set of 71 representative complete genome sequences sampled between 1918 and 2006, we show that segmental reassortment has played an important role in the genomic evolution of A/H1N1 since 1918. Specifically, we demonstrate that an A/H1N1 isolate from the 1947 epidemic acquired novel PB2 and HA genes through intra-subtype reassortment, which may explain the abrupt antigenic evolution of this virus. Similarly, the 1951 influenza epidemic may also have been associated with reassortant A/H1N1 viruses. Intra-subtype reassortment therefore appears to be a more important process in the evolution and epidemiology of H1N1 influenza A virus than previously realized. Author Summary The periodic occurrence of influenza epidemics in humans caused by viruses of the A/H1N1 subtype remains a key question in viral epidemiology and evolution and a major issue for public health. Since the first documentation of A/H1N1 in humans in 1918, this virus has been associated with a variety of epidemics and influenza vaccine failures. Using 71 representative whole-genome sequences of A/H1N1 influenza virus sampled between 1918 and 2005, we show that reassortment occurs frequently throughout the evolutionary history of this virus. Critically, two of these reassortment events appear to be associated with particularly severe epidemics, those of 1947 and 1951. Our analysis reveals that the virus associated with the 1947 epidemic was composed of genome segments with differing phylogenetic histories, suggesting that this virus was created through an intra-subtype reassortment event. Notably, of the two main antigenic proteins, the segment encoding the HA (hemagglutinin) is related to isolates circulating in a later time period, while the NA (neuraminidase) is related to earlier sampled isolates. This explains previous observations that the HA circulating at this time exhibited extensive antigenic drift while the NA appeared to be conserved. In addition, a virus likely associated with the 1951 epidemic also appears to have been generated by a reassortment event. Overall, our findings suggest that reassortment is an important factor in the long-term evolution of influenza A virus, including the periodic emergence of epidemic viruses. However, to more fully capture the evolutionary history of this important virus, additional sequencing of influenza viruses from earlier time periods is clearly needed. Introduction Influenza A viruses of the H1N1 subtype, which circulated in humans from 1918–1957, and then again from 1977 to the present day, have had a significant epidemiological impact in humans. The most debated evolutionary question relating to this virus is how, and from where, A/H1N1 emerged in such a virulent form in 1918 to kill 20–50 million humans in the global influenza pandemic at the time of World War I, arguably the most severe single disease event in history [1],[2]. Perhaps as perplexing, however, is the evolutionary pattern of A/H1N1 influenza viruses following the 1918 pandemic, which is marked by a series of highly unusual occurrences, including the ‘pseudo-pandemic’ of 1947 [3] and several other severe epidemics in the 1920's through the 1950's, a twenty-year disappearance and sudden reappearance in 1977, and cycles of alternating dominance with the H3N2 influenza A virus subtype ever since. Following the 1918 pandemic, the A/H1N1 influenza virus continued to circulate in humans, causing seasonal epidemics of varying severity [4] and also in swine, as ‘classical’ swine influenza [5]. In the post-pandemic period, epidemiologically severe outbreaks occurred in 1928–1929, 1932–1933, 1936–1937, and 1943–1944 in the United Kingdom [4] and the United States [6]. In 1947, the A/H1N1 virus underwent a major antigenic change that caused a total vaccine failure [7]. The virus was globally distributed much like a pandemic virus, but mortality was relatively low [8]. The virus was renamed ‘A-prime’ based on its antigenic divergence [9] from the previously characterized human A/H1N1 viruses of the early 1940's, although subsequent sequence analysis showed that these 1947 viruses were still of the A/H1N1 subtype, yet with numerous nucleotide and amino acid differences in antigenic regions of the hemagglutinin (HA) [10]. However, the evolutionary and epidemiological processes that precipitated such extensive divergence are currently unclear. Another unusually severe A/H1N1 epidemic occurred in 1950–1951 [11], in which mortality levels in the United Kingdom and Canada exceeded those of both the 1957 and 1968 pandemics, again without a change in antigenic subtype [12]. In 1957, the A/H1N1 virus disappeared and was replaced by a novel H2N2 reassortant virus [13]. The A/H1N1 virus then resurfaced in 1977 after a twenty-year disappearance, causing an epidemic in children who lacked antibodies from prior exposure [14]–[17]. However, this emergent A/H1N1 did not replace the dominant H3N2 subtype [18], so that A/H1N1 and H3N2 have co-circulated to the present day. Although H3N2 has caused the majority of influenza A virus infections in recent decades, H1N1 periodically predominates during milder epidemic seasons [19]. Three of the past ten influenza seasons in the United States have been dominated by A/H1N1, all of which were mild and did not exceed the epidemic threshold for the proportion of deaths attributed to pneumonia and influenza (for example ref. [20]). How cross-immunity and other mechanisms dictate the cyclical interplay between the A/H1N1 and A/H3N2 subtypes in humans remains a major epidemiological question. The role played by segmental reassortment in the evolution of A/H1N1 is also unclear. It is well established that reassortment between influenza isolates from different host species can generate viruses with pandemic potential. As case in point, reassortment between avian and human influenza A viruses generated the novel H2N2 and H3N2 strains that caused global human pandemics in 1957 and 1968, respectively [13],[21]. In addition, inter-subtype reassortment has been detected between co-circulating A/H1N1 and A/H3N2 viruses [22],[23], occasionally generating hybrid A/H1N2 viruses [24]. More recently, reassortment among influenza A viruses within the H3N2 subtype has been shown to generate both antigenically and genetically novel viruses, including those associated with vaccine strain mismatches [25]. To date, however, few studies of reassortment frequency in human A/H1N1 influenza viruses have been undertaken. The A/H1N1 subtype is thought to experience less rapid antigenic evolution (‘antigenic drift’) than viruses of the A/H3N2 subtype, as reflected by the relatively infrequent need to update the A/H1N1 component of the human influenza vaccine [26],[27]. Whereas the A/H3N2 component of the influenza vaccine has been changed four times over the past seven years to account for frequent antigenic drift in this subtype, the A/New Caledonia/22/1999 (H1N1) strain has been used in the vaccine in each season from 2000–2001 to 2006–2007. This lower rate of antigenic drift in A/H1N1 presumably relates to reduced selection pressures, as reflected by the lower rates of nonsynonymous (dN) to synonymous substitutions (dS) per site (depicted in the ratio dN/dS) in A/H1N1 compared to A/H3N2 [28]. Understanding why A/H1N1 and A/H3N2 differ in their evolutionary and epidemiological dynamics remains a critical research question. Herein, we undertook an expansive analysis of long-term evolutionary patterns in A/H1N1 influenza A viruses, using 71 whole-genome sequences (major coding regions) sampled between 1918 and 2006 and representing 17 different countries on five continents. As our focus is on revealing the extent of intra-subtype reassortment within A/H1N1, and particularly how reassortment events might relate to large-scale epidemiological patterns, we inferred phylogenetic trees for each individual gene segment and determined the extent and pattern of topological incongruence among them [25]. Results Phylogenetic analysis of A/H1N1 genome sequences from 1918–2006 The phylogenetic trees inferred for all eight genome segments of 71 A/H1N1 viruses reveal a strong temporal structure, comprising a main trunk lineage that links viruses from successive epidemics, and short, transient, side branches [26],[29] (Figures 1
Occasionally, two sections on a given tree merge into a single section due to the absence of the trunk branch that separates these sections on other segment phylogenies and, in some instances, the by action of reassortment. For example, in the PB1, NA, and M segments, sections II and III are merged into a single section (II) due to the close phylogenetic relationship of clades B, C, and D as a result of reassortment. Similarly, sections VI and VII are merged into a single VI section for the PB2, NA, and M gene segments, as clades F and G are positioned closely together on these three phylogenies (in the absence of trunk branch #6). Sections IV and V are also merged on the NA phylogeny. The most frequent merging of sections occurs on the NA phylogeny; here, sections III, V, and VII are absent such that the NA phylogeny is comprised of only six of nine sections, and which results in the very long trunk branches #3 and #7. These two branches are especially notable on the NA tree in that they are characterized by an unusually high number of amino acid changes, reflecting the large evolutionary distance between sections II and IV (19 amino acid changes) and sections VI and VIII (15 amino acid changes) (Table 1). In marked contrast, no sections of the HA phylogeny are merged, resulting in a tree in which evolutionary change is more evenly distributed across all eight trunk branches. Across the viral genome as a whole, the greatest number of amino acid changes occurs along the main trunk lineages of the HA tree (n = 63), followed by the NA tree (n = 55), strongly supporting the long-term action of immune selection (antigenic drift) on these glycoproteins.
The smallest number of amino acid changes occurs along branch #4, which connects isolates from the 1950's (section IV) with those from the 1970's (section V). Thus, little A/H1N1 evolution is evident over the twenty-year period of the virus's global disappearance [30], supporting earlier suggestions that this subtype was most likely accidentally reintroduced into human circulation from a laboratory environment [3],[31]. Notably, our analysis indicates that the influenza viruses that re-emerged in the 1970's were more closely related in all gene segments to a group of viruses sampled from the late 1940's, in particular to isolate A/Roma/1949, supporting earlier serological and partial sequence analyses [16],[30],[32] Multiple reassortment events within A/H1N1 In general, most of the ten clades A–J fall within the same topological section in each of the segment phylogenies. For example, on all eight phylogenies, clade A is positioned within section I, clades B and C fall in section II, clades H and I are contained in section VIII, and clade J is found within section IX. In contrast, clades D, E, F, and G have markedly different topological (section) positions among segments, revealing the past history of reassortment (Figures 1 A summary of the differing phylogenetic patterns of each viral genome segment, highlighting the occurrence of reassortment, is provided in Figure 9 Due to the action of reassortment, Clade D, containing viruses sampled between 1940 and 1947, occupies a variety of phylogenetic positions. This topological movement reflects how genomic segments are related to a variety of clades sampled from different time periods (Figures 1 Clade E (representing viruses isolated in 1950–1957) similarly exhibits different topological patterns across the eight segment phylogenies (Figures 1 The action of reassortment is also apparent from the variable phylogenetic positions of clades F and G. For seven of eight gene segments (PB2, PB1, PA, HA, NP, NA, and M), clade F is positioned within section VI. In contrast, clade F falls into section VII for the NS segment due to a topological reversal between clades F and G, indicative of reassortment. Clade G is also found in various topological positions, suggesting further reassortment, although phylogenetic resolution in this portion of the tree is insufficient to infer the action of reassortment with any statistical certainty. For half of the viral genome (PB1, PA, HA, and NP), clade G clearly falls into section VII, topologically distinct from clade F in section VI. In contrast, for the remainder of the genome, clade G is either positioned with clade F in section VI (PB2, NA, M), or occupies section VI in isolation (NS). Overall, we can characterize four distinct evolutionary patterns within the genome of A/H1N1 viruses (Figure 9 Discussion Although the eight genome segments of H1N1 influenza A viruses exhibited generally congruent evolutionary patterns during their circulation in the twentieth century, we found strong phylogenetic evidence for several distinct reassortment events affecting specific segments. Analyses of the complete genomes of a large number of recently sampled human H3N2 influenza A viruses have demonstrated the co-circulation of multiple distinct clades and frequent intra-subtype reassortment events among them [25],[33]. Although far fewer A/H1N1 viral genomes from the 1930's–1950's are available for analysis, even with this limited sample distinct co-circulating clades and several intra-subtype reassortment events are apparent, suggesting that the evolutionary complexity of recent A/H3N2 viruses was likely recapitulated in A/H1N1 viruses from this era. Further, while adaptation to growth in embryonated chicken eggs is likely to influence patterns of viral evolution in early sampled isolates, and particularly in the HA [34], such bias will largely affect tip (terminal) rather than trunk branches of phylogenetic trees [34], and so will have no major bearing on the results presented here. Interestingly, in two cases these observed reassortment events occurred concurrently with the unusual influenza epidemics of 1947 and 1951. In both these years influenza viruses emerged that displayed certain characteristics of pandemic viruses, including unusually high morbidity and mortality impact, but which did not acquire new gene segments through reassortment with other influenza virus subtypes. Hence, our analysis is compatible with intra-subtype reassortment events involving multiple segments playing a role in the genesis of these unusual epidemic viruses, a phenomenon that was only recently demonstrated to occur among influenza viruses of the A/H3N2 subtype [25]. The most notable observation from our study is that the clade D reassortment event appears to coincide with the unusually severe post-World War II influenza epidemic of 1947, which caused a total influenza vaccine failure worldwide although with relatively low mortality [7]. Previous analyses revealed that the HA1 region of the hemagglutinin of these 1947 epidemic influenza isolates, including A/Fort Monmouth/1/47, were highly divergent from those of the less virulent isolates sampled between 1943–1945, including A/Weiss/43 and A/Marton/43 [10], and which are represented by the co-circulating clades B and C in this study (Figures 1 Our analysis also suggests, more tentatively, that the virus responsible for the unusually severe 1951 epidemic in some geographic regions may have been generated by a genomic reassortment event. Based on the phylogenetic movement of clade E, a major reassortment event clearly occurred in the early 1950's to create a virus with novel PB1, PA, NP, NA, M, and NS gene segments in combination with older PB2 and HA genes that were closely related to those circulating in the 1940's. The extensive evolutionary change in six of the eight viral gene segments generated in this reassortment event may resolve the quandary over how a virus that displayed little antigenic drift in HA caused such a severe epidemic [11]. It has been previously suggested that the severity of the 1951 epidemic in the UK and Canada was related to the high transmissibility of the virus circulating in these countries, which perhaps resulted from enhanced viral replication within hosts [36]. Our finding that clade E retained its HA gene but acquired two polymerase genes – PB1 and PA – through reassortment suggests that these viruses indeed may have been antigenically similar but replicated with enhanced efficiency. However, it is not known whether the A/Fort Worth/1950 and/or A/Albany/12/1951 isolates contained within clade E were derived from the severe 1951 epidemic. Although both isolates were circulating at the time of the epidemic, and the A/Albany/12/1951 isolate (sampled during April 1951) originates in an area of the northeastern United States that experienced particularly high mortality [6], no influenza virus sequence that is known with certainty to have been sampled from the severe 1951 epidemic is available in the public domain. Additional sequencing of isolates from the 1950's, particularly from areas most affected by the epidemic, including the United Kingdom and Canada, is clearly required to evaluate the role of reassortment in generating the influenza viruses that caused this unusual epidemic. While the epidemiological significance of the reassortment events documented here remains unresolved, particularly in the case of the 1951 epidemic, our analysis shows for the first time that large-scale intra-subtype reassortment events, involving all eight segments of the viral genome, have played an important role in the evolutionary history of the A/H1N1 virus. Materials and Methods Influenza viruses used in this study All complete genome sequences of influenza A/H1N1 virus data were collected as part of the Influenza Genome Sequencing Project (http://www.niaid.nih.gov/dmid/genomes/mscs/influenza.htm) for the period 1918–2006 [37]. All sequence data were downloaded from the National Center for Biotechnology Information Influenza Virus Resource (http://www.ncbi.nlm.nih.gov/genomes/FLU/FLU.html). A total of 420, 419, 418, 480, 448, 547, 475, and 444 full-length A/H1N1 sequences were available for the PB2, PB1, PA, HA, NP, NA, M, and NS segments, respectively, the vast majority of which were collected from Australia, New Zealand or the United States during the period 1995–2005. After removing isolates for which not all nucleotide sequences for all eight genome segments were available, phylogenetically closely related sequences from the same year and location, and sequences acquired directly from swine, a total of 71 representative full-length influenza A/H1N1 virus sequences from 17 countries spanning five continents were used in the analysis. Full-length sequences were available for all segments except the HA gene of the A/Brevig Mission/1/1918 virus, for which a phylogenetically related virus sampled from the same year – A/South Carolina/1/18 – was used in its place for this segment. GenBank accession numbers for all sequences used in this study are listed in Table S1. Phylogenetic analysis Sequence alignments were manually constructed for the major coding regions of each of the eight genomic segments: PB2 (2,277 nt), PB1 (2,271 nt), PA (2,148 nt), HA (1,698 nt), NP (1,494 nt), NA (1,407 nt), M1 (756 nt), and NS1 (690 nt). Because the small M2 and NS2 proteins are involved in overlapping reading frames, they were not included in the analysis. Maximum likelihood (ML) phylogenetic trees were inferred for each of the eight genome segments sequences using the PAUP* package [38]. In each case, the best-fit model of nucleotide substitution was identified by MODELTEST [39] as the general reversible GTR+I+Γ4 model, with the frequency of each substitution type, proportion of invariant sites (I), and the gamma distribution of among-site rate variation with four rate categories (Γ4) estimated from the empirical data (parameter values available from the authors on request). In all cases TBR (tree bisection-reconnection) branch-swapping was then utilized to determine the optimal tree. A bootstrap resampling process (1,000 replications) using the neighbor-joining (NJ) method was used to assess the robustness of individual nodes on the phylogeny, incorporating the ML substitution model. Finally, fixed amino acid changes along major branches of the phylogeny were identified using the parsimony algorithm available in the MacClade program [40]. Viral clades were identified as clusters of isolates sharing a common ancestor with >70% bootstrap support on all eight phylogenies. Due to the comparatively low resolution of the M and NS phylogenies, itself a function of the short length and conserved nature of the M and NS segments, isolates from clades E and I formed clusters supported by bootstrap values that did not reach 70%. However, these isolates clearly clustered together across all segment phylogenies and so are depicted as a single clade for the sake of clarity and consistency. Table S1 GenBank accession numbers and background information for 71 complete genome sequences of influenza A virus subtype H1N1 used in the phylogenetic analysis. For simplicity, accession numbers refer to the PB2 gene. Clade letters and section numbers correspond to those given in Figure 1 (0.13 MB DOC) Click here for additional data file.(131K, doc) Acknowledgments We thank all those who have generously contributed their viruses to the Influenza Genome Sequencing Project. Footnotes The authors have declared that no competing interests exist. The research undertaken in this study was funded in part by NIH grant number GM080533-01 and this research was also supported in part by the Intramural Research Program of the NIH, the NIAID, and the Fogarty International Center. References 1. Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918–1920 “Spanish” influenza pandemic. Bull Hist Med. 2002;56:105–115. [PubMed] 2. Taubenberger JK, Morens DM. 1918 influenza: the mother of all pandemics. Emerg Infect Dis. 2006;12:15–22. [PubMed] 3. Kilbourne ED. Influenza pandemics of the 20th century. Emerg Infect Dis. 2006;12:9–14. [PubMed] 4. Logan WP, MacKay DG. Development of influenza epidemics. Lancet. 1951;260:284–285. 5. Taubenberger JK, Reid AH, Janczewski TA, Fanning TG. Integrating historical, clinical and molecular data in order to explain the origin and virulence of the 1918 Spanish influenza virus. Phil Trans R Soc Lond B. 2001;356:1829–1839. [PubMed] 6. Collins SD, Lehmann J. Trends and epidemics of influenza and pneumonia, 1918–1951. Public Health Reports. 1951;66:1487–1507. [PubMed] 7. Rasmussen AF, Stokes J, Smadel JE. The army experience with influenza, 1946–1947. Am J Epidemiol. 1948;47:142–149. 8. Sartwell PE, Long AP. The army experience with influenza, 1946–1947. Am J Epidemiol. 1948;47:135–141. 9. Salk JE, Suriano PC. Importance of antigenic composition of influenza virus vaccine in protecting against the natural disease. Am J Public Health. 1949;39:345–355. [PubMed] 10. Kilbourne ED, Smith C, Brett I, Pokorny BA, Johansson B, et al. The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic. Proc Natl Acad Sci USA. 2002;99:10748–10752. [PubMed] 11. Isaacs A, Gledhill AW, Andrewes CH. Influenza A viruses: laboratory studies, with special reference to European outbreak of 1950-1. Bull World Hlth Org. 1952;6:287–315. 12. Viboud C, Tam T, Fleming D, Miller M, Simonsen L. 1951 influenza epidemic, England and Wales, Canada, and the United States. Emerg Infect Dis. 2006;12:661–668. [PubMed] 13. Scholtissek C, Rohde W, Von Hoyningen V, Rott R. On the origin of the human influenza virus subtype H2N2 and H3N2. Virology. 1978;87:13–20. [PubMed] 14. Weekly Epidemiological Record. Influenza. 1977;52:401. 15. Weekly Epidemiological Record. Influenza. 1978;53:22–23. 16. Kendal AP, Noble GR, Skehel JJ, Dowdle WR. Antigenic similarity of influenza A (H1N1) viruses from epidemics in 1977–1978 to “Scandinavian” strains isolated in epidemics of 1950–1951. Virology. 1978;89:632–636. [PubMed] 17. Scholtissek C, von Hoyningen V, Rott R. Genetic relatedness between the new 1977 epidemic strains (H1N1) of influenza and human influenza strains isolated between 1947 and 1957 (H1N1). Virology. 1978;89:613–617. [PubMed] 18. Cox NJ, Black RA, Kendal AP. Pathways of evolution of influenza A (H1N1) viruses from 1977 to 1986 as determined by oligonucleotide mapping and sequencing studies. J Gen Virol. 1989;70:299–313. [PubMed] 19. Simonsen L, Clarke ML, Schonberger LB, Arden NH, Cox NJ, et al. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Disease. 1998;178:53–60. [PubMed] 20. Centers for Disease Control and Prevention. Update: influenza activity – United States and worldwide, 2006–2007 and composition of the 2007–2008 influenza vaccine. MMWR. 2007;56:789–794. [PubMed] 21. Kawaoka Y, Krauss S, Webster RG. Avian-to-human transmission of the PB1 gene of influenza A viruses in 1957 and 1968 pandemics. J Virol. 1989;63:4603–4608. [PubMed] 22. Young JF, Palese P. Evolution of human influenza A viruses in nature: recombination contributes to genetic variation of H1N1 isolates. Proc Natl Acad Sci USA. 1979;76:6547–6551. [PubMed] 23. Xu X, Rocha EP, Regenery HL, Kendal AP, Cox NJ. Genetic and antigenic analyses of influenza A (H1N1) viruses, 1986–1991. Virus Res. 1993;28:37–55. [PubMed] 24. Guo Y, Xu X, Cox NJ. Human influenza A (H1N2) viruses isolated from China. J Gen Virol. 1992;73:383–388. [PubMed] 25. Holmes EC, Ghedin E, Miller N, Taylor J, Bao Y, et al. Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol. 2005;3:e300. [PubMed] 26. Hay AJ, Gregory V, Douglas AR, Lin YP. The evolution of human influenza viruses. Phil Trans R Soc Lond B. 2001;356:1861–1870. [PubMed] 27. Centers for Disease Control and Prevention. Update: influenza activity – United States and worldwide, 2006–2007 and composition of the 2007–2008 influenza vaccine. MMWR. 2007;56:789–794. [PubMed] 28. Wolf Y, Viboud C, Holmes EC, Koonin EV, Lipman DJ. Long intervals of stasis punctuated by bursts of positive selection in the seasonal evolution of influenza A virus. Biol Direct. 2006;1:34. [PubMed] 29. Ferguson NM, Galvani AP, Bush RM. Ecological and immunological determinants of influenza evolution. Nature. 2003;422:428–433. [PubMed] 30. Nakajima K, Desselberger U, Palese P. Recent human influenza A (H1N1) viruses are closely related genetically to isolates isolated in 1950. Nature. 1978;274:334–339. [PubMed] 31. Oxford JS. Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology. Rev Med Virology. 2000;10:119–133. [PubMed] 32. Nakajima S, Nishikawa F, Nakajima K. Comparison of the evolution of recent and late phase of old influenza A (H1N1) viruses. Microbiol Immunol. 2002;44:841–847. [PubMed] 33. Nelson MI, Simonsen L, Viboud C, Miller MA, Taylor J, et al. Stochastic processes are key determinants of short-term evolution in influenza A virus. PLoS Pathog. 2006;2:e125. [PubMed] 34. Bush RM, Fitch WM, Bender CA, Cox NJ. Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol Biol Evol. 1999;16:1457–1465. [PubMed] 35. Cox NJ, Subbarao K. Global epidemiology of influenza: past and present. Annu Rev Med. 2000;51:407–421. [PubMed] 36. Viboud C, Tam T, Fleming D, Handel A, Miller M, Simonsen L. Transmissibility and mortality impact of epidemic and pandemic influenza, with emphasis on the unusually deadly 1951 epidemic. Vaccine. 2006;24:6701–6707. [PubMed] 37. Ghedin E, Sengamalay NA, Shumway M, Zaborsky J, Feldblyum T, et al. Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature. 2005;437:1162–1166. [PubMed] 38. Swofford DL. PAUP*: Phylogenetic analysis using parsimony (*and other methods) version 4.0 [computer program]. Sunderland, Massachusetts: Sinauer Associates; 2003. 39. Posada D, Crandall KA. MODELTEST: testing the model of DNA substitution. Bioinformatics. 1998;14:817–818. [PubMed] 40. Maddison DR, Maddison WP. MacClade. Analysis of Phylogeny and Character Evolution, version 4.0 [computer program]. Sunderland, Massachusetts: Sinauer Associates; 2000. |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||
Bull Hist Med. 2002 Spring; 76(1):105-15.
[Bull Hist Med. 2002]Emerg Infect Dis. 2006 Jan; 12(1):15-22.
[Emerg Infect Dis. 2006]Emerg Infect Dis. 2006 Jan; 12(1):9-14.
[Emerg Infect Dis. 2006]Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29; 356(1416):1829-39.
[Philos Trans R Soc Lond B Biol Sci. 2001]Public Health Rep. 1951 Nov 16; 66(46):1487-1516.
[Public Health Rep. 1951]Am J Public Health Nations Health. 1949 Mar; 39(3):345-55.
[Am J Public Health Nations Health. 1949]Proc Natl Acad Sci U S A. 2002 Aug 6; 99(16):10748-52.
[Proc Natl Acad Sci U S A. 2002]Emerg Infect Dis. 2006 Apr; 12(4):661-8.
[Emerg Infect Dis. 2006]Virology. 1978 Jun 1; 87(1):13-20.
[Virology. 1978]Virology. 1978 Sep; 89(2):613-7.
[Virology. 1978]J Gen Virol. 1989 Feb; 70 ( Pt 2)():299-313.
[J Gen Virol. 1989]J Infect Dis. 1998 Jul; 178(1):53-60.
[J Infect Dis. 1998]Virology. 1978 Jun 1; 87(1):13-20.
[Virology. 1978]J Virol. 1989 Nov; 63(11):4603-8.
[J Virol. 1989]Proc Natl Acad Sci U S A. 1979 Dec; 76(12):6547-51.
[Proc Natl Acad Sci U S A. 1979]Virus Res. 1993 Apr; 28(1):37-55.
[Virus Res. 1993]J Gen Virol. 1992 Feb; 73 ( Pt 2)():383-7.
[J Gen Virol. 1992]Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29; 356(1416):1861-70.
[Philos Trans R Soc Lond B Biol Sci. 2001]MMWR Morb Mortal Wkly Rep. 2007 Aug 10; 56(31):789-94.
[MMWR Morb Mortal Wkly Rep. 2007]Biol Direct. 2006 Oct 26; 1():34.
[Biol Direct. 2006]PLoS Biol. 2005 Sep; 3(9):e300.
[PLoS Biol. 2005]Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29; 356(1416):1861-70.
[Philos Trans R Soc Lond B Biol Sci. 2001]Nature. 2003 Mar 27; 422(6930):428-33.
[Nature. 2003]Nature. 1978 Jul 27; 274(5669):334-9.
[Nature. 1978]Emerg Infect Dis. 2006 Jan; 12(1):9-14.
[Emerg Infect Dis. 2006]Rev Med Virol. 2000 Mar-Apr; 10(2):119-33.
[Rev Med Virol. 2000]Virology. 1978 Sep; 89(2):632-6.
[Virology. 1978]Microbiol Immunol. 2000; 44(10):841-7.
[Microbiol Immunol. 2000]PLoS Biol. 2005 Sep; 3(9):e300.
[PLoS Biol. 2005]PLoS Pathog. 2006 Dec; 2(12):e125.
[PLoS Pathog. 2006]Mol Biol Evol. 1999 Nov; 16(11):1457-65.
[Mol Biol Evol. 1999]PLoS Biol. 2005 Sep; 3(9):e300.
[PLoS Biol. 2005]Proc Natl Acad Sci U S A. 2002 Aug 6; 99(16):10748-52.
[Proc Natl Acad Sci U S A. 2002]Annu Rev Med. 2000; 51():407-21.
[Annu Rev Med. 2000]Vaccine. 2006 Nov 10; 24(44-46):6701-7.
[Vaccine. 2006]Public Health Rep. 1951 Nov 16; 66(46):1487-1516.
[Public Health Rep. 1951]Nature. 2005 Oct 20; 437(7062):1162-6.
[Nature. 2005]Bioinformatics. 1998; 14(9):817-8.
[Bioinformatics. 1998]